Ingrid G Winkler

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 4

Top Topics

Hematopoietic Stem Cell

Monoclonal Antibody

Top Venues

Nature communications

Immunology and cell biology

This page only lists publications with an associated author ORCID identifier.

Publications

Julie M Davies, Kristen J Radford, Jacob Begun, Jean-Pierre Lévesque, Ingrid G Winkler
Adhesion to E-selectin primes macrophages for activation through AKT and mTOR. Immunology and cell biology 99 (6) (2021)
Kavita Bisht, Crystal McGirr, Seo-Youn Lee, Hsu-Wen Tseng, Whitney Fleming, Kylie A Alexander, Taichi Matsumoto, Valérie Barbier, Natalie A Sims, Gerhard Müller-Newen, Ingrid G Winkler, Halvard Bonig, Jean-Pierre Lévesque
Oncostatin M regulates hematopoietic stem cell (HSC) niches in the bone marrow to restrict HSC mobilization. Leukemia (2021)
Kavita Bisht, Marion E Brunck, Taichi Matsumoto, Crystal McGirr, Bianca Nowlan, Whitney Fleming, Thomas Keech, Graham Magor, Andrew Charles Perkins, Julie Davies, Gail Walkinshaw, Lee Flippin, Ingrid G Winkler, Jean-Pierre Lévesque
HIF prolyl hydroxylase inhibitor FG-4497 enhances mouse hematopoietic stem cell mobilization via VEGFR2/KDR. Blood advances 3 (3) (2020)
Valerie Barbier, Johanna Erbani, Corrine Fiveash, Julie M Davies, Joshua Tay, Michael R Tallack, Jessica Lowe, John L Magnani, Diwakar R Pattabiraman, Andrew C Perkins, Jessica Lisle, John E J Rasko, Jean-Pierre Lévesque, Ingrid G Winkler
Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance. Nature communications 11 (1) (2020)